Advicenne provides an update on its activities following its Annual General Meeting
17:45 p.m. CET, June 15, 2021
PARIS, France, 17:45 p.m. CET, June 15, 2021 – Advicenne (Euronext: ADVIC), a specialty
pharmaceutical company dedicated to developing and commercializing innovative treatments for
those suffering from rare renal diseases, provides an update on its activities following its Annual
General Meeting, which was held virtually on June 14, 2021.